{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T13:28:23Z","timestamp":1756992503436,"version":"3.41.2"},"reference-count":19,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,9,2]],"date-time":"2024-09-02T00:00:00Z","timestamp":1725235200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Digit. Health"],"abstract":"<jats:sec><jats:title>Aim<\/jats:title><jats:p>A clinical study was performed to test the usability of a smartphone eye-scanning app at a needle exchange facility to detect drug use to support therapy.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>The study recruited 24 subjects who visited the facility one to three times, making a total of 40 visits. During each visit the subjects underwent testing for non-convergence (NC), nystagmus (NY), and pupillary light reflex (PLR) using a smartphone-based eHealth system. The collected eye data were transformed into key features that represent eye characteristics. During each visit, a time-line follow-back interview on recent drug use and a usability questionnaire were completed.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Technical usability of the smartphone eye-scanning app was good for PLR and NC, where key features were generated in 82%\u201391% of the cases. For NY, only 60% succeeded due to cognitive problems to follow instructions. In most cases, subjects were under the influence of drugs when participating in the tests, with an average of 2.4 different drugs ingested within the last 24\u2005h. The key features from PLR could distinguish use of opioids from central stimulants. The usability questionnaire results indicate that 23 of the 24 subjects could perform the eye-scanning by themselves after a short training, even when under severe influence of drugs. The caregiver assessed that 20 out of the 24 challenging subjects could potentially perform these tests in an indoors, home-like environment.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Smartphone-based eye-scanning is functional in a patient population with heavy drug use, also when under the influence of drugs. The use of central stimulants can be distinguished from the use of opioids.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fdgth.2024.1394322","type":"journal-article","created":{"date-parts":[[2024,9,2]],"date-time":"2024-09-02T05:10:30Z","timestamp":1725253830000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Smartphone-based drug testing in the hands of patients with substance-use disorder\u2014a usability study"],"prefix":"10.3389","volume":"6","author":[{"given":"Johan","family":"M\u00e5nflod","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tove","family":"Gumbel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Winkvist","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markku D.","family":"H\u00e4m\u00e4l\u00e4inen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karl","family":"Andersson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2024,9,2]]},"reference":[{"volume-title":"European Drug Report 2023: Trends and Developments","year":"2023","key":"B1"},{"volume-title":"Principles of Drug Addiction Treatment: A Research-Based Guide","year":"2018","key":"B2"},{"key":"B3","doi-asserted-by":"publisher","first-page":"eaau1184","DOI":"10.1126\/science.aau1184","article-title":"Changing dynamics of the drug overdose epidemic in the United States from 1979 through 2016","volume":"361","author":"Jalal","year":"2018","journal-title":"Science"},{"key":"B4","doi-asserted-by":"publisher","first-page":"108019","DOI":"10.1016\/j.pharmthera.2021.108019","article-title":"Treatment of overdose in the synthetic opioid era","volume":"233","author":"Skolnick","year":"2022","journal-title":"Pharmacol Ther"},{"key":"B5","doi-asserted-by":"publisher","first-page":"103555","DOI":"10.1016\/j.drugpo.2021.103555","article-title":"Trends in opioid-related crime incidents and comparison with opioid overdose outcomes in the United States","volume":"101","author":"Chen","year":"2022","journal-title":"Int J Drug Policy"},{"key":"B6","doi-asserted-by":"publisher","first-page":"108350","DOI":"10.1016\/j.drugalcdep.2020.108350","article-title":"The economic burden of opioid use disorder and fatal opioid overdose in the United States, 2017","volume":"218","author":"Florence","year":"2021","journal-title":"Drug Alcohol Depend"},{"year":"","key":"B7","article-title":"List of countries by GDP (nominal)"},{"key":"B8","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1177\/14034948221075025","article-title":"Increases in drug overdose deaths in Norway and the United States during the COVID-19 pandemic","volume":"51","author":"Friedman","year":"2023","journal-title":"Scand J Public Health"},{"key":"B9","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1258\/acb.2011.011116","article-title":"Screening for drugs of abuse: which matrix, oral fluid or urine?","volume":"48","author":"Allen","year":"2011","journal-title":"Ann Clin Biochem"},{"key":"B10","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1097\/00007691-200404000-00020","article-title":"Detection times of drugs of abuse in blood, urine, and oral fluid","volume":"26","author":"Verstraete","year":"2004","journal-title":"Ther Drug Monit"},{"key":"B11","doi-asserted-by":"publisher","first-page":"22776","DOI":"10.1038\/s41598-021-02137-x","article-title":"A comprehensive breath test that confirms recent use of inhaled cannabis within the impairment window","volume":"11","author":"DeGregorio","year":"2021","journal-title":"Sci Rep"},{"key":"B12","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/s1529-1839(04)70037-8","article-title":"An evaluation of pupil size standards used by police officers for detecting drug impairment","volume":"75","author":"Richman","year":"2004","journal-title":"Optometry"},{"key":"B13","article-title":"Testing the validity of pupillometer technology against traditional drug screening instruments","volume":"75","author":"Fazari","year":"2011","journal-title":"Fed Probat"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1282022","DOI":"10.3389\/fdgth.2023.1282022","article-title":"Evaluation of 6 years of eHealth data in the alcohol use disorder field indicates improved efficacy of care","volume":"5","author":"Wallden","year":"2024","journal-title":"Front Digit Health"},{"key":"B15","doi-asserted-by":"publisher","first-page":"e2336914","DOI":"10.1001\/jamanetworkopen.2023.36914","article-title":"Telemedicine buprenorphine initiation and retention in opioid use disorder treatment for Medicaid enrollees","volume":"6","author":"Hammerslag","year":"2023","journal-title":"JAMA Netw Open"},{"article-title":"Quality assurance in medical facial images with respect to ambient illumination","year":"2023","author":"H\u00e4m\u00e4l\u00e4inen","key":"B16"},{"key":"B17","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1007\/s00194-015-0023-8","article-title":"The potential of infrared pupillography in routine police traffic checks","volume":"25","author":"Monticelli","year":"2015","journal-title":"Rechtsmedizin"},{"year":"","key":"B18","article-title":"Clinical investigation KCClin01 NCT05731999"},{"key":"B19","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1159\/000519541","article-title":"Amphetamine-type stimulant dependence and association with concurrent use of cocaine, alcohol, and cannabis: a cross-sectional study","volume":"28","author":"Berndt","year":"2022","journal-title":"Eur Addict Res"}],"container-title":["Frontiers in Digital Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fdgth.2024.1394322\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,2]],"date-time":"2024-09-02T05:10:34Z","timestamp":1725253834000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fdgth.2024.1394322\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,2]]},"references-count":19,"alternative-id":["10.3389\/fdgth.2024.1394322"],"URL":"https:\/\/doi.org\/10.3389\/fdgth.2024.1394322","relation":{},"ISSN":["2673-253X"],"issn-type":[{"type":"electronic","value":"2673-253X"}],"subject":[],"published":{"date-parts":[[2024,9,2]]},"article-number":"1394322"}}